Episode 24 explores the thrombotic consequences of infection and sepsis, potentially devastating complications that can contribute to organ dysfunction and worsen patient outcomes. Join us in spreading awareness and advancing patient care!

In episode 23, we explore how heat affects the human body, with a special focus on cardiovascular health, venous function, and thrombotic risk. Join us in raising awareness and play an active role in safeguarding health!

In our 22nd episode, we take a closer look at cirrhotic portal vein thrombosis, a clinically significant vascular condition characterized by the thrombotic occlusion of the portal vein in patients with underlying liver disease. Together, let’s raise awareness and contribute to better patient outcomes!

Our 21st issue focuses on Catastrophic Antiphospholipid Syndrome, a very rare but devastating form of APS marked by the rapid development of extensive thrombosis across multiple organs. Let’s increase awareness and help drive better outcomes for patients!

Our 20th article explores Post‑Thrombotic Syndrome, a common yet often underestimated consequence of DVT, which can develop in up to 50% of patients despite appropriate anticoagulation. Join us in raising awareness and advancing patient care!

In the 19th article of our series, we shine a spotlight on intracardiac thrombosis, a rare yet serious condition where clots form within the heart’s chambers or structural components, underscoring how crucial early detection is to prevent embolization, stroke and other life‑threatening complications. Join us in spreading knowledge and improving patient care!

In the 18th article of our series, we explore the substantial impact of postoperative thrombotic events, with a special emphasis on orthopedic and trauma procedures, areas where venous thromboembolism continues to be a major contributor to complications and postoperative deaths. Join us in spreading knowledge and improving patient care!

In the 17th article of our series, we focus on Philadelphia-negative myeloproliferative neoplasms, a group of rare hematologic malignancies marked by the excessive production of mature blood cells and a strong association with thrombosis. Let’s continue spreading awareness and driving meaningful change together!

At Werfen, our mission to Powering Patient Care inspires continuous efforts to deepen clinical insights and improve patient outcomes. In this episode, we explore Disseminated Intravascular Coagulation (DIC), a paradoxical condition that simultaneously predisposes to excessive clotting and severe bleeding.

Werfen is dedicated to Powering Patient Care and promoting global awareness of thrombosis to improve health outcomes.

This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise the risk of thrombosis and vascular disorders, especially in individuals with pre-existing conditions.

At Werfen, our dedication to Powering Patient Care is reflected by our efforts to deepen clinical understanding of thrombosis and support better clinical outcomes.

In this episode we highlight Splanchnic Venous Thrombosis (SVT), a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs.

Although the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help minimize the risk while travelling

At Werfen, our mission to Powering Patient Care includes advancing global understanding of thrombosis to improve health outcomes.

To mark International TTP Day, observed last Wednesday, this issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.

In this new episode, we focus on Cerebral Venous Thrombosis (CVT), a rare yet serious condition involving blood clot formation in the brain’s venous system. 

This episode explores the relationship between two complex medical conditions—Pulmonary Embolism (PE) and Chronic Obstructive Pulmonary Disease (COPD)—which often present similar symptoms, making accurate diagnosis particularly difficult.

At Werfen, our mission to Powering Patient Care includes advancing global understanding of thrombosis to improve health outcomes.

In honor of Antiphospholipid Syndrome Awareness Month, this issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.

This episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is expected to rise further. 

This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.

Werfen is committed to Powering Patient Care and raising global awareness about thrombosis to improve overall health outcomes.
In this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is a crucial, as DVT is often mistakenly seen as primarily affecting the elderly.

In this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. 

Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
Knowing thrombosis risk factors, prevention strategies, and treatment options is crucial for Healthcare Professionals (HCPs) to effectively manage and prevent VTE.

Werfen is committed to Powering Patient Care and raise global awareness of thrombosis to enhance patient outcomes.
Thrombophilia discoveries reflect the dynamic nature of medical science and its continuous quest for better healthcare solutions.

Werfen is committed to Powering Patient Care and raise global awareness of thrombosis to enhance patient outcomes. 
By exploring together the history of thrombosis, we can better appreciate the advancements in our medical knowledge and technology.

Thrombosis: A Silent Killer in Need of Urgent Attention
Werfen is committed to Powering Patient Care and increase global awareness of thrombosis to enhance patient outcomes.